Arcadia Biosciences, Inc. (NASDAQ:RKDA) Stock Short Interest Report for September

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 88,752 shares, an increase of 824.0% from the September 15th total of 9,605 shares. Currently, 3.9% of the company’s stock are short sold. Based on an average daily trading volume, of 4,634,429 shares, the short-interest ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Arcadia Biosciences in a report on Tuesday, September 22nd. One investment analyst has rated the stock with a Sell rating. According to MarketBeat.com, Arcadia Biosciences presently has a consensus rating of “Sell”.

Arcadia Biosciences Price Performance

Shares of RKDA stock traded down $0.01 during mid-day trading on Friday, hitting $0.26. 390,238 shares of the stock traded hands, compared to its average volume of 2,768,454. The stock has a market cap of $636,698.70, a P/E ratio of -0.06 and a beta of 0.56. The stock’s fifty day moving average is $0.47 and its two-hundred day moving average is $0.79. Arcadia Biosciences has a 52-week low of $0.22 and a 52-week high of $5.72.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The firm had revenue of $1.44 million during the quarter, compared to the consensus estimate of $1.90 million.

About Arcadia Biosciences

Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing plant-based products and crop technologies designed to address health, nutrition and sustainability needs. The company has worked to improve the nutritional profile and agricultural performance of crops through biotechnology and plant-breeding programs.

Arcadia’s product portfolio has included GoodWheat, a line of wheat varieties and wheat-based foods developed to contain reduced levels of gluten and other targeted nutritional characteristics.